MedTrace Logo

Ginseng HRG80 in Stress and Fatigue

NCT03947554 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-07-05

No results posted yet for this study

Summary

This study evaluates the effects of a specific herbal preparation of Panax ginseng in preventing symptoms of stress in healthy individuals.

Conditions

  • Psychological Stress

Interventions

DIETARY_SUPPLEMENT

HRG80 Panax ginseng

Panax ginseng containing 63.4 mg ginsenosides

DIETARY_SUPPLEMENT

Panax ginseng

Panax ginseng containing 19.6 mg ginsenosides

DIETARY_SUPPLEMENT

Placebo

800 mg excipient

Sponsors & Collaborators

  • Botalys SA

    collaborator UNKNOWN

  • EuroPharma, Inc.

    lead INDUSTRY

Principal Investigators

  • Areg Hovhannisyan, PhD, Dr Sci · Sports Medicine and Anti-Doping Service Republican Centre

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2019-06-15
Completion
2019-07-01

Countries

  • Armenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03947554 on ClinicalTrials.gov